How to Source Sulfadoxine + Pyrimethamine (SP) – tablets for Pharmaceutical Formulation
Sulfadoxine + Pyrimethamine (SP) – tablets (Tablet, 500 mg sulfadoxine + 25 mg pyrimethamine; 500 mg + 75 mg) is classified under Medical Aid. It is therapeutically aligned with reference brands such as Generic formulations. This guide highlights key sourcing factors buyers should consider when procuring high-quality Sulfadoxine + Pyrimethamine (SP) – tablets for formulation, R&D, or bulk manufacturing.
Product Overview:
Sulfadoxine inhibits bacterial dihydropteroate synthase, while pyrimethamine blocks dihydrofolate reductase, disrupting folate synthesis in malaria parasites. This combination effectively kills Plasmodium falciparum, providing rapid malaria prophylaxis and treatment. Benefits include high efficacy, synergy against resistant strains, and simplified dosing in endemic regions.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Sulfadoxine + Pyrimethamine (SP) – tablets must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Sulfadoxine + Pyrimethamine (SP) – tablets is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Sulfadoxine + Pyrimethamine (SP) – tablets is more than procurement—it’s a strategic partnership. With its tablet form and 500 mg sulfadoxine + 25 mg pyrimethamine; 500 mg + 75 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Sulfadoxine + Pyrimethamine (SP) – tablets.
Frequently Asked Questions For Sourcing of Sulfadoxine + Pyrimethamine (SP) – tablets
What is the typical lead time for Sulfadoxine + Pyrimethamine (SP) – tablets?
Lead times range from 4–6 weeks depending on supplier and region.
Is Sulfadoxine + Pyrimethamine (SP) – tablets available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Sulfadoxine + Pyrimethamine (SP) – tablets require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Sulfadoxine + Pyrimethamine (SP) – tablets?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Sulfadoxine + Pyrimethamine (SP) – tablets?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Sulfadoxine + Pyrimethamine (SP) – tablets?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Sulfadoxine + Pyrimethamine (SP) – tablets suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Sulfadoxine + Pyrimethamine (SP) – tablets be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.